Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR in Acute Schizophrenia
NCT00779506Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in schizophrenia, sponsored by AstraZeneca. Started Nov 2008; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00779506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779506.